DIN 02559153 — TREMFYA I.V. 200 MG
TREMFYA I.V. is a solution of Guselkumab marketed by JANSSEN INC. The full Guselkumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02559153
- Brand name
- TREMFYA I.V.
- Active ingredient
- Guselkumab
- Strength
- 200 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- Interleukin-23 (IL-23) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Guselkumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02469758 | TREMFYA | 100 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02566877 | TREMFYA | 100 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02559145 | TREMFYA | 200 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02487314 | TREMFYA ONE-PRESS | 100 MG | SOLUTION | JANSSEN INC | MARKETED |